Systemic lupus erythematosus (SLE) can be a severe and potentially life-threatening
disease that often represents a therapeutic challenge because of its heterogeneous organ …

Therapeutic plasma exchange (TPE or PLEX) is used in a broad range of autoimmune
diseases, with the goal of removing autoantibodies from the circulation. A newer approach …

Nephritis has long been considered one of the most ominous components of systemic lupus
erythematosus. Accumulations of immune complexes and lymphoid cells in several …

Twenty‐six patients, who received plasmapheresis (PP) either alone or synchronized with
cyclophosphamide (IV‐CYC/PP), are retrospectively reviewed from Medline searches and …

Objective: To analyse the effects of rigorous immunoglobulin removal by immunoadsorption
(IAS) on proteinuria (primary outcome variable), disease activity (SIS, SLEDAI, ECLAM), and …

Product liability: The publisher can give no guarantee for all the information contained in this
book. This does also refer to information about drug dosage and application thereof. In every …

Lipoprotein apheresis is an effective treatment for severe disorders of lipid metabolism. It is
the only life prolonging therapy for patients with homozygous familial hypercholesterolemia …

The catastrophic antiphospholipid syndrome (CAPS) is a life-threatening sub-entity of the
antiphospholipid syndrome (APS) resulting in multiorgan failure and a mortality rate that may …

Neuropsychiatric manifestations of systemic lupus erythematosus (NPSLE) are among the
main causes of morbidity and mortality attributed to lupus activity. Conventional NPSLE …

Background. Systemic lupus erythematosus (SLE) is characterized by pathogenic
autoantibodies, which can be removed by extracorporeal procedures. While previous …